Latest Industry Insights

Chromatography-free mass spectrometry boosts throughput, cuts costs and simplifies drug monitoring – learn how Bruker and RECIPE are leading the way.

In this interview, Morten Bern, chief executive officer of Evosep, discusses the innovations behind the Eno system, the evolving needs of pharmaceutical customers and the growing focus on high-throughput, high-sensitivity proteomics solutions.

In this interview, we explore how Cerno’s vendor-neutral software solutions enhance mass spectrometry data analysis.

Unlike injectable weight loss drugs that often serve as a temporary fix, Elcella seeks to naturally activate the gut’s own appetite-regulating mechanisms, offering a new path to long-term health and sustainable weight management.

Seer joined Technology Networks for a conversation about its new Proteograph® Product Suite at ASMS 2025.

David Curtin discusses how the integration of MALS detectors with Empower software enhances biopharmaceutical QC, aligns with evolving regulatory demands and supports the future of complex biologic product analysis.

Learn how CD34+ stem cells may help heart attack patients recover. A look at cutting-edge cell therapies and what's coming next in cardiac care.

In this interview, Technology Networks spoke with Kara Egan, CEO and co-founder of Teal Health, to learn more about how they are reshaping cervical cancer prevention.

As the global population ages, the need for innovative solutions to extend health span and combat age-related diseases has never been more urgent. LinkGevity, a pioneering AI-enabled drug discovery company, is at the forefront of this challenge.

Mushroom mycelium can be turned into high-quality insulation and other building materials. To learn more, Technology Networks spoke with the founder of MycoTile, a Kenyan company that specializes in mycelium-based construction materials.